SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Wednesday reported a loss of $19.3 million in its first quarter.
The South Plainfield, New Jersey-based company said it had a loss of 46 cents per share.
The biopharmaceutical company posted revenue of $56.1 million in the period.
PTC Therapeutics expects full-year revenue in the range of $260 million to $295 million.
PTC Therapeutics shares have increased 84 percent since the beginning of the year. In the final minutes of trading on Wednesday, shares hit $30.74, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT